Dr Henriette Coetzer has joined RowdMap as chief clinical risk officer to help health plans and physicians transition to pay-for-value arrangements.
According to RowdMap, Coetzer is a world leader in using public health data to create transparency and transform healthcare practices and policies creating interventions.
RowdMap works with health plans, hospitals and groups of physicians to profile unnecessary spend and no value care in their populations and within their networks of physicians, then matches this to the best risk arrangements and pay-for-value programs for their populations and performance.
The work Dr Coetzer is doing on clinical risk is crucial to RowdMap’s mission:
“Few people in the world have the unique combination of skills, expertise and experience and that’s why we are ecstatic to have Dr Coetzer on board,” said RowdMap in a statement.
“Dr Henriette Coetzer is an influential name in using health data to create transparency in healthcare practices and policies. Her extensive and personal history with diverse clinical practices, data and policy is particularly well-suited for her work with RowdMap to help health plans, government payers, providers, and hospital systems develop risk-readiness strategies to excel as they transition from fee-for-service to pay-for-value.”
Perhaps best known for her pioneering work on the Dartmouth Atlas of Unwarranted Variation at BUPA (British United Provident Association) and Health Dialog where she served as vice president of Clinical Analytics, Coetzer has served as global medical director at Towers Watson and product development at Healthways.
She is a director of clinical transformation for the National Health Service (NHS) in the UK at a Clinical Commissioning Group (CCG), the Accountable Care Organizations (ACOs) of the UK. She also practices as an urgent care physician.
Coetzer joined RowdMap’s board of advisers in 2014 and will continue in that position as she now takes on the office of chief clinical risk officer where she is responsible for bringing together clinical practice and economic drivers and impact both at an individual physician level as well as across an ecosystem.
“The work Dr Coetzer is doing on clinical risk is crucial to RowdMap’s mission. Few people in the world have the unique combination of skills, expertise and experience to handle RowdMap’s mission to use public data to help health plans and providers transition to pay-for-value arrangements and that’s why we are ecstatic to have Dr Coetzer as part of RowdMap Inc.’s senior leadership,” said Melanie Rosenthal, chief executive officer, RowdMap.
Dr Henriette Coetzer, RowdMap, US
